InsiderDB

Lobbying disclosures · Lobbying report

CDNA: second_quarter 2026 lobbying report

-Medicare coverage of molecular testing for solid organ allograft rejection -Medicare payment of clinical laboratory tests; implementation of Sec 216 of the Protecting Access to Medicare Act of 2014 (PL 113-93) -Prior authorization of molecular tests Living Donor Protection Act (LDPA) S1522, HR4582,HR4583

Follow CDNA
Became public
Jul 20, 2026, 1:53 PM EDT
Event / period date
Not stated
Collected
Nov 10, 2026, 10:59 AM EST

Why this is connected

Exact legal-name match: CareDx, Inc. (https://www.sec.gov/Archives/edgar/data/1217234/).

Reported lobbying amounts

Expenses: $90,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/b93de93c-6824-4d9e-bb10-d476af488574/","filing_uuid":"b93de93c-6824-4d9e-bb10-d476af488574","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/b93de93c-6824-4d9e-bb10-d476af488574/print/","filing_document_content_type":"text/html","income":null,"expenses":"90000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kimberly Linthicum","dt_posted":"2026-07-20T13:53:41-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"8000 Marina Blvd","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Brisbane","registrant_state":"CA","registrant_zip":"94005","registrant":{"id":401109878,"url":"https://lda.gov/api/v1/registrants/401109878/","house_registrant_id":77187,"name":"CAREDX, INC.","description":null,"address_1":"8000 Marina Blvd","address_2":null,"address_3":null,"address_4":null,"city":"Brisbane","state":"CA","state_display":"California","zip":"94005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KIM LINTHICUM","contact_telephone":"+1 202-997-7117","dt_updated":"2026-07-30T10:10:36.918537-04:00"},"client":{"id":68693,"url":"https://lda.gov/api/v1/clients/68693/","client_id":68693,"name":"CAREDX, INC.","general_description":"Clinical laboratory and transplant support services","client_government_entity":null,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-07-30"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"-Medicare coverage of molecular testing for solid organ allograft rejection -Medicare payment of clinical laboratory tests; implementation of Sec 216 of the Protecting Access to Medicare Act of 2014 (PL 113-93) -Prior authorization of molecular tests","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151322,"prefix":null,"prefix_display":null,"first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LINTHICUM","suffix":null,"suffix_display":null},"covered_position":"LD, Rep. Bob Franks","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Living Donor Protection Act (LDPA) S1522, HR4582,HR4583","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151322,"prefix":null,"prefix_display":null,"first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LINTHICUM","suffix":null,"suffix_display":null},"covered_position":"LD, Congressman Bob Franks","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in CDNA

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.